Clinical Trial Update: Study to Evaluate ARD-101 in Adults With Obesity [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating ARD-101 for obesity and that trial results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ARD-101

Snippet

Sponsor: Aardvark Therapeutics, Inc. | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2025-01-22